Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone + gabapentin fixed-dose combination dose-finding study in painful diabetic neuropathy
2018-000133-12Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of trazodone and gabapentin in diabetic neuropathy and diabetic polyneuropathy (DPN) (4 arms), sponsored by Angelini Pharma. Primary endpoint: Change from baseline in average daily pain score at Day 56. Started Jun 2018; status: completed.
02
Drugs
trazodonegabapentin
03
Conditions
diabetic neuropathydiabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2018-000133-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000133-12.